Tilray Brands, Inc. - stock earnings
TLRY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -49.0 million USD | 193.8 million USD |
| 2023Q3 | -55.9 million USD | 176.9 million USD |
| 2023Q2 | -119.8 million USD | 184.2 million USD |
| 2023Q1 | -1.2 billion USD | 145.6 million USD |
| 2022Q4 | -61.6 million USD | 144.1 million USD |
| 2022Q3 | -65.8 million USD | 153.2 million USD |
| 2022Q2 | -457.8 million USD | 153.3 million USD |
| 2022Q1 | 43.2 million USD | 151.9 million USD |
| 2021Q4 | 5.8 million USD | 155.2 million USD |
| 2021Q3 | -41.6 million USD | 168.0 million USD |
| 2021Q2 | 33.6 million USD | 142.2 million USD |
| 2021Q1 | -92.9 million USD | 123.6 million USD |
| 2020Q4 | -283.3 million USD | 120.6 million USD |
| 2020Q3 | -3.9 million USD | 110.6 million USD |
| 2020Q2 | -71.3 million USD | 109.7 million USD |
| 2020Q1 | -6.0 million USD | 90.4 million USD |
| 2019Q4 | 4.3 million USD | 107.4 million USD |
| 2019Q3 | 12.3 million USD | 94.4 million USD |
| 2019Q2 | 12.3 million USD | 92.7 million USD |
| 2019Q1 | -82.3 million USD | 56.0 million USD |
| 2018Q4 | -82.3 million USD | 56.0 million USD |
| 2018Q3 | 16.3 million USD | 10.2 million USD |
| 2018Q2 | -4.1 million USD | 9.1 million USD |
| 2018Q1 | -4.1 million USD | 9.1 million USD |
| 2017Q4 | 10.1 million USD | 8.0 million USD |
| 2017Q3 | 5.0 million USD | 6.6 million USD |
| 2017Q2 | 11.9 million USD | 4.8 million USD |
| 2017Q1 | -2.0 million USD | 4.0 million USD |
| 2016Q4 | 3.8 million USD | 3.9 million USD |
| 2016Q3 | 703870 USD | 3.9 million USD |
| 2016Q2 | 683896 USD | 3.3 million USD |
| 2016Q1 | 972378 USD | 2.3 million USD |
| 2015Q4 | 2745 USD | 2.0 million USD |
| 2015Q3 | -322410 USD | 1.5 million USD |
| 2015Q2 | -360088 USD | 717978 USD |
| 2015Q1 | -420008 USD | 402509 USD |
| 2014Q4 | -2.5 million USD | 41193 USD |
| 2014Q3 | -6112 USD | ? USD |
| 2014Q2 | -7840 USD | ? USD |
| 2014Q1 | -62528 USD | ? USD |
| 2013Q4 | -46542 USD | ? USD |
| 2013Q3 | -3761 USD | ? USD |
| 2013Q2 | -6954 USD | ? USD |
| 2013Q1 | -3667 USD | ? USD |
| 2012Q4 | -12674 USD | ? USD |
| 2012Q3 | -19483 USD | ? USD |
| 2012Q2 | -12763 USD | ? USD |
| 2012Q1 | -17186 USD | ? USD |
| 2011Q4 | -65346 USD | ? USD |
| 2011Q3 | -3424 USD | ? USD |
TLRY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.4 billion USD | 627.1 million USD |
| 2022 | -434.1 million USD | 628.4 million USD |
| 2021 | -336.0 million USD | 513.1 million USD |
| 2020 | -61.0 million USD | 391.0 million USD |
| 2019 | -61.0 million USD | 391.0 million USD |
| 2018 | -12.2 million USD | 175.2 million USD |
| 2017 | 22.8 million USD | 28.6 million USD |
| 2016 | 3.1 million USD | 15.2 million USD |
| 2015 | 305123 USD | 6.5 million USD |
| 2014 | -5.3 million USD | 443703 USD |
| 2013 | -41989 USD | ? USD |
| 2012 | -96428 USD | ? USD |
TLRY
Price: $1.80
52 week price:
Earnings Per Share: -0.44 USD
P/E Ratio: -0.79
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 12.7 million
Market Capitalization: 1.7 billion